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Mother’s Own Milk Compared With
Formula Milk for Feeding Preterm or
Low Birth Weight Infants: Systematic
Review and Meta-analysis
Natalie A. Strobel, PhD,a Claire Adams, PhD,a Daniel R. McAullay, PhD,a Karen M. Edmond, MBBS, PhDb

We assessed the effect of feeding preterm or low birth weight infants with infant
formula compared with mother’s own milk on mortality, morbidity, growth,
neurodevelopment, and disability.

OBJECTIVES:

abstract

We searched Medline (Ovid), Embase (Ovid), and Cochrane Central Register of
Controlled Studies to October 1, 2021.

METHODS:

Forty-two studies enrolling 89 638 infants fulfilled the inclusion criteria. We did not
find evidence of an effect on mortality (odds ratio [OR] 1.26, 95% confidence interval [CI]
0.91–1.76), infection (OR 1.52, 95% CI 0.98–2.37), cognitive neurodevelopment (standardized
mean difference 1.30, 95% CI 3.53 to 0.93), or on growth parameters. Formula milk
feeding increased the risk of necrotizing enterocolitis (OR 2.99, 95% CI 1.75–5.11). The
Grading of Recommendations Assessment, Development, and Evaluation certainty of evidence
was low for mortality and necrotizing enterocolitis, and very low for neurodevelopment and
growth outcomes.

RESULTS:

In preterm and low birth weight infants, low to very low-certainty evidence
indicates that feeding with infant formula compared with mother’s own milk has little effect
on all-cause mortality, infection, growth, or neurodevelopment, and a higher risk of
developing necrotizing enterocolitis.

CONCLUSIONS:
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SUPPLEMENT ARTICLE

Preterm (<37 weeks’ gestation) and
low birth weight (LBW) (<2.5 kg)
infants have limited nutrient
reserves at birth and are subject to
many physiologic and metabolic
stresses that increase their nutrient
needs.1 Formula milks (eg, artificial
infant formulas) can be manipulated
to contain higher amounts of
nutrients (such as protein) than
mother’s own milk.2,3 However,
formula milks do not contain the
immunomodulators and nutrients
present in human milk that
stimulate the immune system,
protect the immature gut, and
promote neurodevelopment.2,4
There are many new infant
formulas; however, the last
systematic reviews were conducted
in 2011 and 2019 and there have
been no recent reviews of the
effectiveness of infant formula and
other formula milks compared with
mother’s own milk on outcomes in
preterm and LBW infants.5,6
Our primary objective was to evaluate
the effect of formula milks compared
with mother’s own milk on primary
outcomes (mortality, morbidity,
growth, neurodevelopment, and
disability) in preterm and LBW
infants. Our secondary objectives
were to determine the effect of
gestational age (<32 weeks), birth
weight (<1.5 kg), and exclusivity of
mother’s own milk (ie, if the mother’s
own milk was the sole diet [ie, 100%
mother’s own milk]), on health
outcomes of preterm or LBW infants.

METHODS
This review was registered in
PROSPERO (#CRD42021283008).
Preferred Reporting Items for
Systematic Reviews and MetaAnalyses-Protocol guidance was
followed.7
Type and Setting of Included
Studies
We included randomized controlled
studies (RCTs), cohort,

cross-sectional, and case-control
studies. Case reports and studies
published in abstract form only
were excluded. All settings were
included, such as home and health
facility, within any country.

Participants
Only preterm or LBW infants were
included. Normal weight or term
infants were excluded.

Intervention and Control Groups
The intervention was any formula
milk which included artificial infant
formula (including cow’s milk
protein, soy protein, other protein,
or hydrolyzed formula) or other
animal milk. Infants could receive
mother’s own milk or donor human
milk, as long as most (>50%) of the
milk was formula. Infants had to
receive the intervention in the
neonatal period (0–27 days).
The control was mother’s own milk.
Infants could also receive other
milks (ie, donor human milk,
formula milk, formula) as long as
most (>50%) of the milk was
mother’s own.
In both the intervention and control
groups, the infants could receive any
water-based fluids.

Outcomes
The primary outcome was infant allcause mortality.
The secondary outcomes were:
 necrotizing enterocolitis as defined by the study authors;
 severe infections (eg, sepsis,
pneumonia, meningitis) as defined by the study authors;
 neurodevelopment defined as:
neurodevelopmental scores measured using validated assessment
tools in the main domains (cognitive, motor, language) of standardized assessment tools such
as the Bayley Scales of Infant and
Toddler Development, Third
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Edition, or the Weschler Wechsler Intelligence Scale for
Children;
 disability defined as: nonambulant cerebral palsy; developmental quotient >2 SDs below the
population mean; blindness
(visual acuity <6 of 60) or
deafness (any hearing impairment requiring or unimproved
by amplification); and
 growth (weight, length, head
circumference, mid-upper arm
circumference, skinfold thickness) absolute change measured
as grams or centimeters, standardized change measured as
z-score, or percentile compared
with a population reference.
The timing of the outcome
assessment was at hospital
discharge and at latest follow-up
time recorded.

Search Methods
This is an update of a 2011
systematic review.5 Electronic
databases were searched from
January 1, 2011, to October 1, 2021.
Databases included Medline (Ovid),
Embase (Ovid), and Cochrane
Central Register of Controlled
Studies. In addition, we completed
manual reference checks of existing
reviews and of papers that were
included in the review. All studies
from the 2011 systematic review
were included.5 Appendix 1
provides the search strategy used
and Appendix 2 shows the Preferred
Reporting Items for Systematic
Reviews and Meta-Analyses flowchart.

Selection of Studies and Data
Extraction
Selection of studies and data
extraction was conducted by 2
authors and followed standard
methods.8 Data extracted included:
country, study design, study setting
(facility [infant born and followedup in the facility until discharge] or
“whole population” [ie, infant born
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and followed-up at home or the
facility]), gestational age, birth
weight, and milks given in
intervention and control groups.

Assessment of Risk of Bias
Two review authors judged the
risk of bias using standard
methods, including the ROBINS-I
tool (risk of bias in nonrandomized
studies of interventions).9 Where
possible, funnel plots and Egger’s
test were used to assess
publication bias.

Measurement of Treatment Effect
For dichotomous data, we
summarized results using risk ratios
and, where this was not possible,
odds ratios (ORs) with 95%
confidence intervals (CIs). For
continuous data, we summarized
results using the mean difference
(MD) with 95% CIs or standardized
mean difference (SMD) when
different methods or scales were
used between studies.10
We considered all studies to be
highly heterogenous, so we used
random-effects models to calculate
pooled estimates for all outcomes.
Where available, we used study
level adjusted effect sizes to
calculate pooled estimates and,
when not available, we used raw
data. We imputed missing data on
the basis of Cochrane methods.8
Restricted maximum likelihood
estimates and Knapp–Hartung SEs
were used.11 We also assessed
forest plots visually for
heterogeneity, and considered Isquared values >50% to represent
substantial heterogeneity. All
analyses were done using Stata 16.1.

Subgroup and Sensitivity Analysis
Our a priori subgroup analyses
were:
1.

gestational age and weight at
birth (studies enrolling only
infants <32 weeks’ gestation or

2.

<1.5 kg at birth compared with
studies that did not restrict
enrollment on the basis of
gestational age or birth weight);
and
exclusivity of mother’s own milk
in the comparison arms (ie,
studies providing mother’s own
milk as the sole diet
[ie, 100% mother’s own milk])
compared with studies providing
other milks (eg, artificial infant
formula, other animal milk,
donor human milk) or foods
(eg, porridge) mixed with
mother’s own milk.

We had also planned to stratify
analyses by high-, middle-, and lowincome settings; however, there
were no low-income studies and
only 3 middle-income studies. We
completed a sensitivity analysis to
determine the robustness of the
growth income by excluding 1 study
that contributed a large sample
size.12 We also planned a sensitivity
analysis excluding studies at serious
or critical risk of bias; however, only
1 study did not have serious or
critical risk of bias.

Summary of Findings and GRADE
Table
We prepared a summary of findings
table for each outcome using
Grading of Recommendations
Assessment, Development and
Evaluation (GRADE) and GRADEPro
guideline development tool software
to assess the quality of the body of
evidence, consistency of effect,
imprecision, indirectness, and
publication bias for each
outcome.13–15

articles reporting on new studies.
Combined with the 19 studies from
the previous review, 42 studies were
included in the narrative review and
36 studies provided data for metaanalysis.12,14–48 Of the 42 studies
there were no RCTs, but there were
34 cohort,12,16,18,20,27–29,31–60 5 crosssectional,19,22,23,26,30 and 3 casecontrol studies17,21,25 (Appendix 3).
Studies were from 21 countries:
Australia, Belgium, Chile, China,
Germany, Ghana, Greece, Hong Kong,
India, Israel, Italy, Japan, Nepal,
Netherlands, New Zealand, Poland,
Romania, Spain, Sweden, the United
Kingdom, and the United States.
Thirty-six studies were implemented
in NICUs and special care nurseries,* and 6 were whole population
studies.17,20,22,32,36,40
In total, there were 89 638 preterm
and/or LBW infants included in the
review, of whom 74 656 were in the
formula group and 14 982 were in the
mother’s own milk group. Of the
infants included in the review, 77 892
were infants born at <32 weeks’
gestational age and 76 796 were
infants weighing <1.5 kg at birth.
Twenty studies enrolled infants <32
weeks’ gestation and/or <1.5 kg at
birth,† and 22 studies did not restrict
enrollment on the basis of gestational
age or birth weight.‡ In the
intervention arm, 24 studies provided
formula milk only (ie, formula was the
sole diet)§ (Appendix 3 and 4). In the
control arm, 9 studies provided mother’s own milk only (ie, mother’s own
milk was the sole
diet).20,26,31–33,36,49,51,52 The proportion
of formula and mother’s own milk provided in each study is given in Appendix 4. All formula milks, where

RESULTS
Study Characteristics
The search resulted in 5170 records.
After screening titles and abstracts,
89 records were retrieved. Sixty-three
reports were excluded with reasons
(Appendix 2). We identified 26 new
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*12,16,18,19,21,23,25–31,33–35,37–39,
41–60
†
12,16,18,22,23,26,30–33,41–46,49–53,
57,59
‡
17,19–21,25,27–29,34–40,47,48,54–56,
58,60
§
12,16–18,21–23,26–29,32–35,37,38,
41–44,49,51,52,55,59,60
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Very lowc,e

⨁

271 (3 observational
studies)

Very lowc,e,g

⨁

Length z-score follow-up: range
39 wk–416 wk

Very lowc,e

⨁

1048 (9 observational
studies)

Very lowc,f

⨁

74130 (6 observational
studies)

Length (cm) at latest
follow-up: mean 58 d

Very lowc,e

⨁

587 (3 observational
studies)

271 (3 observational
studies)

Very lowc,d

Lowa

⨁

⨁⨁

Very lowa

Very lowa,b

⨁

Certainty of the
Evidence (GRADE)

⨁

9673 (5 observational
studies)
3013 (15 observational
studies)
2572 (15 observational
studies)
1560 (8 observational
studies)

No. of Participants
(Studies) Follow-up

—

—

—

—

—

—

OR 1.52 (0.98–2.37)

OR 2.99 (1.75–5.11)

OR 1.26 (0.91–1.76)

Relative Effect
(95% CI)

—

—

The mean growth: weight
z-score (change from
birth to discharge)
ranged from 1.57
to 0.8 points
The mean growth: weight
z-score ranged from
1.31 to 0.5 points
The mean growth: length (cm)
at latest follow-up ranged
from 43.6 to 50.0 cm
The mean growth: length z-score
ranged from 0.9.3 to
0.05 points

258 per 1000

60 per 1000

57 per 1000

MD 0.06 points higher
(0.81 lower–0.92 higher)

MD 0.33 cm more (0.4 fewer–
1.05 more)

MD 0.14 points higher (0.76
lower–1.05 higher)

MD 0.03 points higher
(0.15 lower–0.2 higher)

SMD 0.02 SD higher (0.39
lower–0.43 higher)

14 more per 1000 (5 fewer–39
more)
100 more per 1000 (40 more–186
more)
88 more per 1000 (4 fewer–194
more)
SMD 1.3 SD lower (3.53 lower–0.93
higher)

Risk Difference With Any
Nonhuman Milk

Anticipated Absolute Effects
Risk With Any
Human Milk

Any Nonhuman Milk Compared With Mother’s Own Milk for Preterm or LBW Infants (NRSI Studies)

Weight z-score follow-up: range
39 wk–416 wk

Neonatal mortality at latest
follow-up: mean 116 d
Necrotizing enterocolitis at latest
follow-up: mean 44 d
Sepsis/infection at latest follow-up:
mean 31 d
Child cognitive development;
assessed with validated child
development assessment at
follow-up (range: 91 wk–416 wk)
Child language development;
assessed with validated child
development assessment at
follow-up (range: 39 wk–104 wk)
Weight z-score (change from birth
to discharge) follow-up: mean
52 d

Outcomes

TABLE 1 Summary of Findings Table
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1550 (9 observational studies)

No. of Participants
(Studies) Follow-up
⨁
Very lowc,h

Certainty of the
Evidence (GRADE)
Risk With Any
Human Milk
The mean growth: head
circumference (cm) ranged
from 30.9 to 34.5 cm

—

MD 0.26 cm higher
(0.35 lower–0.87 higher)

Risk Difference With Any
Nonhuman Milk

Anticipated Absolute Effects
Relative Effect
(95% CI)

Any Nonhuman Milk Compared With Mother’s Own Milk for Preterm or LBW Infants (NRSI Studies)

The risk in the intervention group (and its 95% CI) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). Patient or population: preterm or LBW infants (non-randomized studies of intervention); setting: during the neonatal period; intervention: any nonhuman milk; comparison: mother’s own milk. GRADE working group grades of evidence: high certainty, we are very conﬁdent that the true effect lies close to
that of the estimate of the effect; moderate certainty, we are moderately conﬁdent in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different; low certainty, our conﬁdence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect; very low certainty: we have very little conﬁdence in the effect estimate: the true effect is likely to be
substantially different from the estimate of effect. NRSI, nonrandomixed studies of intervention; — not applicable.
a
Downgraded by 2 levels: serious risk of bias (some studies did not account for confounding; it's possible classiﬁcation of intervention status could have been affected by knowledge of the outcome or risk of the outcome).
b
Downgraded by 1 level: serious inconsistency (moderate I2 5 65%).
c
Downgraded by 2 levels: serious risk of bias (no studies accounted for confounding).
d
Downgraded by 1 level: serious inconsistency (high I2 5 99%).
e
Downgraded by 1 level: serious imprecision (small sample size).
f
Downgraded by 1 level: serious indirectness (1 study contributes a large study population).
g
Downgraded by 1 level: serious inconsistency (high I2 5 80%).
h
Downgraded by 1 level: serious inconsistency (high I2 5 88%).

Head circumference (cm) follow-up:
mean 45 d

Outcomes

TABLE 1 Continued

information was provided, were artificial cow’s milk protein-based. There
were no other types of other protein
base (eg, soy or goat milk protein) and
no hydrolyzed formula in the studies.
Seventeen studies provided donor
milk in either the intervention or control groups.*
A total of 36 studies of 88 741 infants
provided data for meta-analysis.

One study contributed 81%
(n 5 72 997) of the overall sample
in the review.12 This study only
reported on growth (ie, did not
report on mortality, morbidity, or
neurodevelopment). After excluding
the infants in this study, there were
10 636 infants in the formula
group and 6005 infants in the
mother’s own milk group. A total
of 5258 were infants born at
<32 weeks’ gestational age and
4128 were infants weighing
<1.5 kg at birth.

Risk of Bias

A risk of bias assessment was
completed for the 36 studies included
in the meta-analysis (Appendix 5). No
studies had low risk of bias. Nineteen
had critical,† 16 had serious,‡ and 1
had moderate31 risk of bias. Most
biases were because of confounding
( Appendix 5). Three studies in the
sepsis outcome had small study effects
(ie, events ranging from 0 to 2) in the
intervention and/or control groups
(Egger test P 5 .0459; funnel plot 5.4)
(Appendix 5).31,47,51 No other outcomes
had obvious publication bias or small
study effects in any analyses (funnel
plots shown in Appendix 5).

Primary Outcomes

At discharge, there was little effect of
the intervention (formula milk) on
the primary outcome (all-cause
mortality) (OR 1.26; 95% CI
0.91–1.76; I2 5 0%; low certainty

*12,17–19,21,28,34,35,37,39,44–48,54,55
†
16,21,26,27,29,30,33,34,36,39,41–43,
47–54,56
‡
12,17–20,22,23,25,28,35,37,38,44–46,55
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evidence; 5 trials, 9625 participants)
(Appendix 6) or the severe infection
outcome (OR 1.52; 95% CI
0.98–2.37; very low certainty
evidence; 15 studies; 2572
participants) (Appendix 6). However,
at discharge, there was a threefold
effect of the intervention on
necrotizing enterocolitis (OR 2.99;
95% CI 1.75–5.11; low certainty
evidence; 15 studies; 3013
participants) (Appendix 6).
At latest follow-up (between 91 and
416 weeks), there was little or no
effect on cognitive
neurodevelopment (SMD 1.30,
95% CI 3.53 to 0.93; very low
certainty evidence; 8 studies, 1560
participants) (Appendix 6).
Similarly, there was little to no
effect on language
neurodevelopment among groups
(SMD 0.02, 95% CI 0.39 to 0.43;
very low certainty evidence; 3
studies, 587 participants)
(Appendix 6).
There was little or no effect of the
intervention on change from birth
to discharge weight z-score (MD
0.03; 95% CI 0.15 to 0.21; very
low certainty evidence; 6 studies,
74 130 participants) (Appendix 6).
At latest follow-up (range 39–416
weeks), there was little to no effect
on weight z-score (MD 0.14; 95% CI
0.76 to 1.05; very low certainty
evidence; 3 studies; 271
participants) (Appendix 6). There
was also little to no evidence of
increase in length (MD 0.33;
95% CI 0.40 to 1.05; very low
certainty evidence; 9 studies;
1048 participants) ( Appendix 6) or
head circumference (MD 0.26;
95% CI 0.35 to 0.87; very low
certainty evidence; 9 studies;
1550 participants) (Appendix 6).
At latest follow-up (range 39–416
weeks), there was little to no
evidence of a difference in length
z-scores among groups (MD 0.06;
95% CI 0.81 to 0.92; very low
certainty evidence; 3 studies; 271

participants) (Appendix 6). No
studies reported other growth
outcomes. Results of the summary
of findings are presented in
Table 1.

compared with the 28 studies
providing other milks (eg, artificial
infant formula, other animal milk,
donor human milk) or foods
(eg, porridge) mixed with mother’s
own milk.

Subgroup and Sensitivity Analysis
There were no differences in the
effect of the intervention in studies
that enrolled infants <32 weeks’
gestation and/or <1.5 kg at birth
compared with studies which did
not restrict enrollment on the basis
of gestational age or birth weight
(Appendix 7).
There were no differences in the
effect of the intervention on primary
outcomes in infants who received
mother’s own milk as a sole diet in
the control group compared with
infants who received a mixture of
mother’s own milk and other milks
(Appendix 8).
A sensitivity analysis was completed
for weight z-score at latest follow-up
by excluding the study with the
large sample size (n 5 72 997).12
After removing this study, there was
little change to results (MD 0.01;
95% CI 0.28 to 0.30; 5 studies;
1133 participants) (Appendix 9).

DISCUSSION
In our systematic review of 42
observational studies enrolling 89 638
preterm and LBW infants, we found
that formula milks had little or no
effect compared with mother’s own
milk on mortality, severe infection,
neurodevelopment, weight, length, or
head circumference at discharge or
latest follow-up, but found a threefold
increase in necrotizing enterocolitis.
We found no differential effect in the
17 studies enrolling only infants
<32 weeks’ gestation or <1.5 kg at
birth compared with the 19 studies
that did not restrict enrollment on the
basis of gestational age or birth
weight. We also found no differential
effect in the 8 studies providing
mother’s own milk as the sole diet
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The previous systematic review of
19 observational studies enrolling
13 027 infants reported low
certainty evidence that formula milk
was associated with an increase in
mortality and the combined
outcome of severe infection and
necrotizing enterocolitis compared
with mother’s own milk in preterm
and LBW infants.5 Formula milk was
also associated with increased
length and decreased
neurodevelopmental outcomes, but
no change in weight outcomes. Our
search found 19 new observational
studies and increased the number of
participants contributing data to
88 741. The addition of new studies
to the mortality (Svenningsen
1982,47 Ruys 201741), length (CostaOrvay 2011,49 Madore 2017,31 Mol
2019,52 Pieltan 2001,54 Ruys
201741) and neurodevelopment
(O’Connor 200339) outcomes did not
substantially change the effects
reported in 2011, though strength of
effect for all outcomes was reduced
and there was no improvement in
the certainty or quality of the
evidence.
Three Cochrane reviews assessed
the effects of human milk in
preterm and LBW infants.6,61,62 In
2019, a Cochrane review of RCTs of
the effects of formula compared
with mother’s own milk located no
trials.6 Also in 2019, a Cochrane
review of RCTs reported moderate
certainty evidence that formula
milk increased weight, length, and
head growth, and had a higher risk
of necrotizing enterocolitis
compared with donor human
milk.62 The trial data did not show
an effect on all-cause mortality, or
on long-term growth or
neurodevelopment. A Cochrane
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review of RCTs in 2020 also
reported moderate certainty
evidence that provision of
multicomponent “fortifier”
(powdered or liquid supplement
with protein, carbohydrate,
vitamins, and minerals added to
human milk) increased short term
in hospital weight, length, and head
circumference compared with
“unfortified” human milk, but
evidence was insufficient to assess
long-term effect on growth,
neurodevelopment, mortality, or
morbidity outcomes.61
In addition to the above review,
3 non-Cochrane reviews were
identified.63–65 Each of these reviews
only investigated 1 outcome per
review, which included a range of inhospital growth outcomes,
bronchopulmonary dysplasia, and
necrotizing enterocolitis. One review
found that, for preterm and LBW
infants, there was inconclusive
evidence on the effect of formula
compared with exclusive human milk
on growth parameters including
change in weight z-scores and head
circumference.65 For preterm infants
receiving exclusive human milk, there
was an improvement in
bronchopulmonary dysplasia
compared with exclusive formula-fed
infants; however, the review
combined both RCTs and
observational studies in their
analysis.64 Similar to our
observational study review, preterm
infants who received human milk had
a reduced risk of developing
necrotizing enterocolitis than those
who received formula.63 However,
unlike our review, these reviews did
not differentiate between whether
infants received mainly mother’s own
milk; only that they received exclusive
(ie, mother’s own milk and/or donor
milk) or any human milk.
Our review had some limitations.
All evidence was low to very low
certainty because of problems with
confounding bias, unexplained

heterogeneity, small sample sizes,
and imprecision in many studies.
Thirty-six studies recruited infants
from health facilities only; there
were only 6 studies that recruited
infants from the whole population.
Twenty-two studies recruited infants
>32 weeks’ gestation. We had also
planned to stratify analyses by high-,
middle-, and low- income settings;
however, there were no low-income
studies and only 3 middle-income
studies. We also planned a sensitivity
analysis excluding studies at serious
or critical risk of bias; however, only
1 study did not have serious or
critical risk of bias. One study
contributed a large sample size
(n 5 72 997) to the growth outcome
and had the potential to bias
outcomes. However, when we
removed this study from the
analysis, there was little change to
the results. There is also much
potential for misclassification
between intervention and control
groups (ie, switching between
formula and mother’s own milk
groups). This is because of the
common practice of providing
formula if mother’s own milk is not
available and active promotion of
breastfeeding in formula-fed infants.
However, in our study, we defined
the intervention and control groups
as those receiving >50% (ie, “most
or majority”) formula (intervention)
or mother’s own milk (control) over
the entire study period. We also
assessed sole or exclusive diet as a
subgroup. Some studies did not
describe the amount of formula or
mother’s own milk provided but we
were able to estimate most or
majority >50% for all studies. Other
strengths of our study were the
comprehensive search strategy and
the inclusion of all study designs.
Overall, in preterm and LBW
infants, our review shows low- to
very low-certainty evidence that
feeding with formula milks
compared with mother’s own milk,

PEDIATRICS Volume 150, number S1, August 2022
Downloaded from http://publications.aap.org/pediatrics/article-pdf/150/Supplement 1/e2022057092D/1343750/peds_2022057092d.pdf
by guest

either as a sole diet or mixed with
other milks, has little effect on allcause mortality, severe infection,
growth, or neurodevelopment, and
a higher risk of developing
necrotizing enterocolitis. However,
the quality of the observational
evidence base must be improved. It
is especially important to control
studies for confounding and to
conduct more studies in lowincome countries and in infants
born and cared for outside of health
facilities.

ABBREVIATIONS
CI: confidence interval
GRADE: Grading of
Recommendations
Assessment,
Development, and
Evaluation
LBW: low birth weight
MD: mean difference
OR: odds ratio
RCT: randomized controlled trial
SMD: standardized mean
difference
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